Recent multi-omics studies have shown aberrant upregulation of COL10A1 in the tumor stroma of breast, pancreatic, and gastric cancers, where it correlates with lymph node metastasis, hematogenous spread, and poor prognosis [12, 13]. This evidence concerns the gene COL10A1 and metastatic malignant neoplasm in the lymph nodes.